Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04109599 · ClinicalTrials.gov registry record · NA

A Digital Intervention to Prevent Initiation of Opioid Misuse in Adolescents in School-based Health Centers

A NA study of Opioid Misuse, sponsored by Yale University.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT04109599 is a NA study of Opioid Misuse that has completed, run by Yale University. The registered enrollment target is 33 participants, below the 5,988-participant average among 13 other Opioid Misuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04109599, a NA study of Opioid Misuse, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This study's specific aims were to: develop a digital intervention as a prevention intervention through focus groups with 40 youth; pilot-test the developed digital intervention with 30 adolescents, using methods from the investigator's prior research; develop implementation strategies and partners through focus groups with 50 School Based Health Alliance affiliates and 30 adolescents from an Advisory Council.

Conditions Studied

Interventions

  • BEHAVIORAL PlaySmart
  • BEHAVIORAL PlaySmart Storyline
  • BEHAVIORAL Play Smart Mini-Game

Study Locations (1)

Connecticut

  • Yale School of Medicine - New Haven

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2021-03-01
Est. Completion 2021-08-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04109599

The ClinicalTrials.gov registry entry for NCT04109599 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,988-participant average among 13 other Opioid Misuse trials with a reported enrollment target (99% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Misuse appearing as the primary indexed condition, and to 3 interventions - of which PlaySmart is the first listed.

NCT04109599 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04109599 about?

NCT04109599 is a clinical study titled "A Digital Intervention to Prevent Initiation of Opioid Misuse in Adolescents in School-based Health Centers". This study's specific aims were to: develop a digital intervention as a prevention intervention through focus groups with 40 youth; pilot-test the developed digital intervention with 30 adolescents, using methods from the investigator's prior research; develop implementation strategies and partners ...

What is the current status of trial NCT04109599?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-03-01. Estimated completion is 2021-08-31.

What conditions does trial NCT04109599 study?

This clinical trial studies the following conditions: Opioid Misuse.

What interventions are being tested in trial NCT04109599?

The interventions under investigation include: PlaySmart (BEHAVIORAL), PlaySmart Storyline (BEHAVIORAL), Play Smart Mini-Game (BEHAVIORAL).

Who is sponsoring clinical trial NCT04109599?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04109599 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Misuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.